Study Supports Using MRD as a Stratification Variable for Patients with TNBC
August 12, 2020
ByHannah Slater

Researchers suggested that these findings support using minimal residual disease as a major stratification variable in all clinical trials to be conducted in patients with triple negative breast cancer.

Study Finds Impact of Surgical Delay on Women with Breast Cancer Due to COVID-19
August 12, 2020
ByHannah Slater

These study results suggested that a longer time to surgery does not lower overall survival for women with early-stage breast cancer who had to delay operations due to the COVID-19 pandemic.

Join CancerNetwork's Survivorship Tweet Chat
August 12, 2020
ByHannah Slater

CancerNetwork® will be hosting a tweet chat on survivorship this Friday, August 14th, at 1 PM EST.

ASH Releases New Guidelines on Treating Newly Diagnosed AML in Older Adults
August 12, 2020
ByHannah Slater

The American Society of Hematology released guidelines that “take providers through the conversations they have with newly diagnosed patients, almost in real-time.”

Mehmet Sitki Copur, MD, on Inadequacies of the Clinical Trials System Highlighted by COVID-19
August 12, 2020
ByHannah Slater

The expert oncologist/hematologist spoke with CancerNetwork® about the challenges brought to light by the current pandemic.

EQUATE Study Shows Early Response Rates in Severe Acute GVHD
August 11, 2020
ByHannah Slater

The study is evaluating itolizumab in patients with severe acute graft-versus-host disease as a first-line treatment concomitant with standard of care.